ÂÜÀòÂÒÂ×

Terry has over 35 years of executive management experience in a variety private equity and public companies including medical/molecular diagnostics, medical devices, software/SAAS and life sciences. He has extensive experience managing merger and acquisition transactions on both the sell and buy side with multiple transactions aggregating over $1 billion in value. Terry has also raised over $300 million in equity and debt capital from public and private markets. Terry’s prior positions include CFO Agena Biosciences, CFO & COO Endoscopic Technologies, CFO & Executive VP Business Development R2 Technology, CFO & COO Bridge Medical, CFO & Senior VP of Operations MetaCreations, CFO & VP Corporate Development Delphi Information Systems, and CFO Integral Systems.